|
Volumn 159, Issue 21, 1999, Pages 2517-2521
|
Improving treatment effectiveness in hypertension
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE PLUS BENAZEPRIL;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
ATENOLOL PLUS CHLORTALIDONE;
BENAZEPRIL;
BENDROFLUMETHIAZIDE PLUS NADOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE;
CALCIUM ANTAGONIST;
CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE;
DILTIAZEM;
DILTIAZEM PLUS ENALAPRIL MALEATE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL MALEATE;
ENALAPRIL MALEATE PLUS FELODIPINE;
ENALAPRIL PLUS HYDROCHLOROTHIAZIDE;
FELODIPINE;
HYDROCHLOROTHIAZIDE;
HYDROCHLOROTHIAZIDE PLUS LISINOPRIL;
HYDROCHLOROTHIAZIDE PLUS LOSARTAN;
HYDROCHLOROTHIAZIDE PLUS PROPRANOLOL;
METOPROLOL TARTRATE;
TIMOLIDE;
TIMOLOL;
TRANDOLAPRIL PLUS VERAPAMIL;
UNCLASSIFIED DRUG;
ANTIHYPERTENSIVE THERAPY;
BLOOD PRESSURE MONITORING;
CLINICAL TRIAL;
DIET THERAPY;
HOME MONITORING;
HUMAN;
HYPERTENSION;
META ANALYSIS;
NOTE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
SODIUM RESTRICTION;
WEIGHT REDUCTION;
ANTIHYPERTENSIVE AGENTS;
DIET THERAPY;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPERTENSION;
OUTCOME ASSESSMENT (HEALTH CARE);
PATIENT COMPLIANCE;
TREATMENT OUTCOME;
|
EID: 0033596069
PISSN: 00039926
EISSN: None
Source Type: Journal
DOI: 10.1001/archinte.159.21.2517 Document Type: Note |
Times cited : (19)
|
References (41)
|